Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betahistine for Meniere's disease
2005-000752-32Phase 3Completed
- Sponsor
- LMU Klinikum
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of betahistine in Meniere Disease (3 arms), sponsored by LMU Klinikum. Primary endpoint: Number of vertigo attacks during the last 3 months of treatment. Started Jun 2005; status: completed.
02
Drugs
betahistine
03
Conditions
Meniere Disease
Beyond the preview
Go deeper on 2005-000752-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000752-32.